Price
No data yet.
Social Signal Score
Analyst Ratings
7 analystsRevenue
$302.25M+344.62%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Brent J. Guerisoli
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 9,700
- Beta
- 1.30
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 2.73
Financials
Revenue
$302.25M+344.6%Net Income
$9.64M+185.0%EBITDA
$21.50M+307.5%Free Cash Flow
$10.13M+620.6%EPS (diluted)
$0.26+114.9%Shares Outstanding (diluted)
36.38M+29.9%Operating Expenses
$20.63MCash & Debt
$18.39MReturn of Capital
$0.00Revenue by Segment (annual)
$946.37MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $947.71M | $29.58M | $0.86 |
| 2024 | $695.24M | $22.56M | $0.72 |
| 2023 | $544.89M | $13.38M | $0.45 |
| 2022 | $473.24M | $6.64M | $0.23 |
| 2021 | $439.69M | $2.70M | $0.08 |
| 2020 | $390.95M | $15.74M | $0.56 |
| 2019 | $338.53M | $2.55M | $0.09 |
| 2018 | $286.06M | $15.68M | $0.56 |
| 2017 | $250.99M | $9.87M | $0.35 |
| 2016 | $217.22M | $7.89M | $0.28 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from PNTG's reported EPS growth of 13.3% a year over 9 years.
- EPS in 5 years
- $1.60
- Implied price
- $52.73
- Return from $37.00
- 7.3% a year
To earn 15.0% a year on these assumptions you'd need to buy at $26.21 — -29.2% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 23 | 28 | 33 | 38 | 43 |
|---|---|---|---|---|---|
| 3.3% | -9.0% | -5.3% | -2.1% | 0.7% | 3.2% |
| 8.3% | -4.5% | -0.7% | 2.6% | 5.5% | 8.2% |
| 13.3% | -0.1% | 3.9% | 7.3% | 10.4% | 13.2% |
| 18.3% | 4.3% | 8.5% | 12.1% | 15.3% | 18.2% |
| 23.3% | 8.7% | 13.0% | 16.8% | 20.2% | 23.2% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
100+0.00%Social Signal Score
Mentions (10)
- Newsglobenewswire.com·9d ago·Neutral
Pennant Group to Participate in the 2026 Stephens Annual Investment Conference EAGLE, Idaho, Nov. 13, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Stephens Annual Investment Conference on November 17, 2026. Lynette Walbom, Chief Financial Officer, and John Gochnour, President and Chief Operating Officer, will par…
View source ↗ - Newsseekingalpha.com·15d ago·Neutral
The Pennant Group, Inc. (PNTG) Q3 2026 Earnings Call Transcript The Pennant Group, Inc. ( PNTG ) Q3 2026 Earnings Call November 5, 2026 12:00 PM EST Company Participants Kirk Cheney - Executive VP, General Counsel & Corporate Secretary Brent Guerisoli - CEO & Chairman John Gochnour - President & COO Lynette Walbom - Chief Financial Officer Andrew Rider - President of Pinnacle Senior Living LLC Conference Call Participants Raj Kumar - Stephens Inc., Research Division Brian Tanquilut - Jefferies L…
View source ↗ - Newsmarketbeat.com·16d ago·Negative
What The Pennant Group (PNTG) Said on Its Q3 Earnings Call The Pennant Group NASDAQ: PNTG reported third-quarter revenue growth of 32% as acquisitions and higher patient volumes lifted its home health and hospice business, though elevated employee benefits costs and senior living integration challenges pressured margins.
View source ↗ - Newsglobenewswire.com·19d ago·Neutral
Pennant Announces Third Quarter 2026 Earnings Release and Call EAGLE, Idaho, Nov. 03, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its third quarter 2026 financial results on Wednesday, November 4, 2026.
View source ↗ - Newszacks.com·62d ago·Neutral
Are You Looking for a Top Momentum Pick? Why The Pennant Group, Inc. (PNTG) is a Great Choice Does The Pennant Group, Inc. (PNTG) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newsseekingalpha.com·65d ago·Neutral
The Pennant Group: The Pros Of Investing Continue To Outweigh The Cons I am maintaining my Buy rating on The Pennant Group driven by robust fundamentals and +200% stock appreciation since April 2023. PNTG delivered 36% revenue growth in 2025 and guides for 25% growth in 2026, with adjusted EPS of $1.34–$1.41 and EBITDA of $94.4–$98M. Strategic acquisitions, disciplined growth, and a culture of operational excellence underpin PNTG's expansion in home health, hospice, and senior living.
View source ↗ - Newszacks.com·66d ago·Neutral
The Pennant Group (PNTG) Moves 6.3% Higher: Will This Strength Last? The Pennant Group (PNTG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
View source ↗ - Newsglobenewswire.com·67d ago·Neutral
Pennant Acquires Real Estate of Mainplace Senior Living in Orange, California EAGLE, Idaho, Sept. 16, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of Pennant affiliated home health, hospice, home care and senior living companies, announced today that, effective September 3, 2026, it acquired the real estate of Mainplace Senior Living (“Mainplace”), a senior living community located in Orange, California. A Pennant affiliated subsidiary has operated Mainplac…
View source ↗ - Newszacks.com·69d ago·Positive
All You Need to Know About The Pennant Group (PNTG) Rating Upgrade to Buy The Pennant Group (PNTG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
View source ↗ - Newsglobenewswire.com·82d ago·Neutral
Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference EAGLE, Idaho, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Jefferies Healthcare Services Conference on September 15, 2026.
View source ↗
Earnings
Wed, Feb 24(in 3 months)
Consensus estimate $0.36 per share
Typical surprise +3.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Nov 4$0.35 vs $0.36miss
- Wed, Aug 5$0.36 vs $0.33beat
- Wed, May 6$0.32 vs $0.31beat
- Wed, Feb 25$0.34 vs $0.31beat
- Wed, Nov 5$0.30 vs $0.29beat
- Wed, Aug 6$0.27 vs $0.26beat
Estimates and results for PNTG via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by PNTG officers and directors.
- Bought
- —
- Sold
- $804k
0 trades
11 trades
- Cheney Kirk Sterlingsold
- Guerisoli Brentsold
- Steik Jason Paulsold
- Guerisoli Brentsold
- Guerisoli Brentsold
- Guerisoli Brentsold
- Guerisoli Brentsold
- Guerisoli Brentsold
89 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in PNTG.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
